Cyntellect Company
Cyntellect provided products for cell analysis, purification, and processing technology to advance research and drug discovery. Cyntellect is dedicated to setting new standards in cell analysis, purification, and processing technology. Cyntellect's products support key applications to advance life science research, biopharmaceutical production, stem cell research and drug discovery. The Company's technology employs in situ, microplate-based cytometry to analyze cells with minimal sample manipulation, and process cells with great precision and efficiency. Cyntellect's expanding cellular analysis and processing portfolio is expected to play an enabling role in the coming age of advanced cell-based diagnostics and therapeutics.
Founded Date:
1997
Total Funding:
$42.6M
Investor Type:
N/A
Employee Number:
11-50
Investment Stage:
N/A
Funding Status:
Late Stage Venture
Number Of Exists:
N/A
Technology:
mHealth
Last Funding Type:
Series E
Investors Number:
2
Industry:
P4 Medicine
Headquarters:
United States